MedPath

Comparison of two drugs named dexmedetomidine and ketamine during general anesthesia (state of unconsciousnessor asleep) in brain surgeries for maintenance of blood pressure, heart rate, depth of sleep and pain control during surgery and post surgery pain management intervention.

Not yet recruiting
Conditions
Malignant neoplasm of brain, unspecified,
Registration Number
CTRI/2022/10/046643
Lead Sponsor
Paras Hospital
Brief Summary

The goals of Neuroanaesthesia are to ensure stable perioperative stable hemodynamics and avoid sudden rise in intracranial pressure (ICP) to prevent acute brain swelling. Craniotomy is associated with intense surgical stimuli causing sympathetic activation which results in marked changes in systemic arterial pressure and cerebral blood flow and hence raised ICP and reduction in cerebral perfusion leading to cerebral ischemia especially in patients with impaired cereberal autoregulation. Hence prevention and control of nociceptive stimulus are of utmost importance. Dexmedetomidine is alpha 2 agonist having sedative, anxiolytic, analgesic and sympatholytic properties. Ketamine is N - methyl D- Aspartate antagonist producing sedation, catalepsy, somatic analgesia and snympathetic nerve  stimulation. This comparison studies aim to assess efficacy of these drugs on intraoperative hemodynamic stability, requirements of other anaesthetic agents, emergence, assessment of postoperative pain and side effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • 1 Patients aged 18.
  • 65 years. 2 American Society of Anesthesiologists I/II. 3 Elective supratentorial craniotomy.
Exclusion Criteria
  • 1 Known allergy to drugs.
  • 2 History of renal,liver, cerebrovascular and cardiovascular (mod/severe) disease.
  • 3 Chronic beta blocker treatment with heart rate or preoperative HR< 50/min.
  • 4 Isolated frontal lobe surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemodynamic parameters - Mean arterial pressure( MAP)Baseline values will be recorded (average of 3) prior to start of study drug. At 0,5 and 10 mins hemodynamic parameters and BIS are recorded. Then at induction , intubation and incision. In between recordings at 15 min interval. At stopping study drug and starting atracurium. Followed by stopping atracurium and tapering propofol. Again recordings will be taken at emergence and extubation
Secondary Outcome Measures
NameTimeMethod
Hemodynamic parameter SBP and DBP, HR, BISRequirement of other annaetshetic drugs propofol, atracurium.

Trial Locations

Locations (1)

Paras Hospital

🇮🇳

Gurgaon, HARYANA, India

Paras Hospital
🇮🇳Gurgaon, HARYANA, India
Dr Ankita Jaiswal
Principal investigator
8527500275
ankita772@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.